MONTREAL, June 15, 2022 /CNW Telbec/ - The Good Shroom Co Inc. (the "Company" or "MUSH") (TSXV: MUSH), through its licensed subsidiary Teonan Biomedical Inc., operates Nordique Royale and Velada cannabis brands.
The Company is pleased to announce that it has expanded its contract with the Government of Quebec which has accepted more cannabis products to be sold in stores across the province beginning this September. Additionally it has also increased its product offering in Ontario beginning this October.
In line with its continued mission of cannabis product innovation the Company has doubled its current listing of products in Quebec with more traditional hash and hash infused products. The Quebec cannabis market is the largest in Canada estimated to be over $650 million in sales.
Since the product launch in Quebec less than six months ago, 6 out of its 9 products have become top sellers in their categories according to https://quebec.weedcrawler.ca/best_sellers. It also has a variety of great reviews from key opinion leaders in Quebec's hash consumer community (See the links below).
MUSH CEO Eric Ronsse stated: "We've created a brand that resonates with a specific demographic which creates loyalty to us and repeat business. The hash community in particular loves our products. Our brands are beginning to have recognition and that's what creates long term value."
Customer product reviews
- https://www.reddit.com/r/sqdc/comments/s2dr11/le_afgan_gold_de_nordique_royale_distribu%C3%A9_par/
- https://www.reddit.com/r/sqdc/comments/uo8an0/hash_afghan_gold_thc_28_cbd_10_nordique_royale/
- https://www.reddit.com/r/sqdc/comments/stz01o/quelquun_a_essay%C3%A9_les_hash_%C3%A9quilibr%C3%A9_de_velada_ou/
- https://www.reddit.com/r/sqdc/comments/s25k8l/hash_nordique_royale_le_choix_du_nord_276_thc_579/ht3gti0/?context=3
- https://www.instagram.com/p/Cd3Tq8QuE-N/
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Corporation with respect to future business activities and sales, including the anticipated orders to be placed by the SQDC. Forward-looking statements are often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions. Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect the Corporation's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Corporation believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements. Among the key factors that could cause actual results to differ materially from those projected are the following: market acceptance of the Company's hash and other cannabis products, changes in the vendor's business or strategy, changes in our supplier's operations and pricing, expectations regarding competition and their pricing strategy; maintaining in good standing all necessary regulatory licenses and authorizations for its products; the benefits, safety, efficacy, dosing and social acceptance of cannabis related products and no material changes in the legal environment; changes in applicable laws and regulations compliance with extensive government regulation; operational risks related to and COVID-19 or other pandemic and supply chain disruptions and shortages. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, and do not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law. Trading in the securities of the Company should be considered highly speculative.
SOURCE The Good Shroom Co Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/15/c7905.html